CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 194 enrolled
Drug / intervention
Salbutamol +6 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03357341
NCT03357341N/ACompleted

Enabling Innovative Respiratory Real World Evidence Generation: Sensor and EHR Integration Pilot Study

GlaxoSmithKline·observational·Posted Nov 29, 2017·Updated Nov 24, 2020

In Brief

An observational study evaluating Mobile spirometer, Device sensor, and 5 other interventions for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 194 participants across 1 site.

Detailed Summary

This is a pilot study that will evaluate the feasibility of collecting increasing amounts of clinical study data from subjects through sensor and web/app based methods and integrating it with data from their EHR to facilitate more efficient and meaningful research with acceptable quality. Approximately 100 subjects with asthma and 100 subjects with chronic obstructive pulmonary disease (COPD) will be enrolled in this prospective study. The subjects will be identified through integrated EHR records following which eligible subjects will receive study devices and training on proper use of the devices at Baseline visit. Data will be collected remotely from subject reports, devices and sensors over six months.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 29, 2017
Enrollment StartJul 23, 2018
Primary CompletionSep 27, 2019
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 8.6 years ago

Interventions

Mobile spirometerdevice

Mobile spirometer will be used to measure FEV1 values weekly.

Device sensordevice

Sensors will be attached to rescue and maintenance inhalers to measure use of rescue medication and maintenance therapy.

Salbutamoldrug

Salbutamol MDI will be given as a rescue medication to be used on an as needed basis in this study.

Activity monitordevice

Subjects will be required to wear activity monitors daily to record their physical activity.

electronic diary cardother

Electronic diary card will be completed daily by subjects in COPD cohort.

CATother

Subjects will be required to complete CAT monthly.

ACTother

Subjects will be required to complete ACT monthly.